Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTSH-assisted radioiodine ablation after thyroidectomy in active moderate-to-severe Graves' orbitopathy
2010-020855-29Phase 4Active
- Sponsor
- University of Messina
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of thyrotropin alfa in Graves' ophthalmopathy (TED) and hyperthyroidism, sponsored by University of Messina. Primary endpoint: Overall Graves' orbitopathy outcome at 12 months. Started Mar 2012; status: active.
02
Drugs
thyrotropin alfa
03
Conditions
Graves' ophthalmopathy (TED)hyperthyroidism
Beyond the preview
Go deeper on 2010-020855-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020855-29.